CANDEL THERAPEUTICS Trademark Information

Trademark by Advantagene, Inc.

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in th...

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 11/1/2018
First Use In Commerce: 1/1/2019
General Information
Word mark: CANDEL THERAPEUTICS
Status/Status Date:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
6/2/2020
Serial Number: 88278673
Filing Date: 1/28/2019
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner:
Advantagene, Inc.
Auburndale, MA 02466
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Advantagene, Inc.
117 Kendrick Street #450
Needham MA 02494
Current Status:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
6/2/2020
Correspondent Search:
Sarah Wilson Lott is a correspondent of CANDEL THERAPEUTICS trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on